Liquiritigenin Attenuated Collagen-Induced Arthritis and Cardiac Complication via Inflammation and Fibrosis Inhibition in Mice
Chemical and Pharmaceutical Bulletin · 2023
DOI: 10.1248/cpb.c22-00684 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, 2023. Verfasst von Xiaoran Ning und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Hebei General Hospital. Hauptthemen laut MEDLINE: Arthritis, Experimental, Arthritis, Rheumatoid, Heart Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, Hebei General Hospital.
- Department of Cardiology, Hebei General Hospital.
- Division of Medical Service, Hebei General Hospital.
Zitieren
APA
Ning, X., Ni, Y., Cao, J., & Zhang, H. (2023). Liquiritigenin Attenuated Collagen-Induced Arthritis and Cardiac Complication via Inflammation and Fibrosis Inhibition in Mice. Chemical and Pharmaceutical Bulletin. https://doi.org/10.1248/cpb.c22-00684
Vancouver
Ning X, Ni Y, Cao J, Zhang H. Liquiritigenin Attenuated Collagen-Induced Arthritis and Cardiac Complication via Inflammation and Fibrosis Inhibition in Mice. Chemical and Pharmaceutical Bulletin. 2023. doi:10.1248/cpb.c22-00684
BibTeX
@article{Ning2023,
author = {Ning, Xiaoran and Ni, Yanhui and Cao, Jingjing and Zhang, Huaxing},
title = {Liquiritigenin Attenuated Collagen-Induced Arthritis and Cardiac Complication via Inflammation and Fibrosis Inhibition in Mice},
journal = {Chemical and Pharmaceutical Bulletin},
year = {2023},
doi = {10.1248/cpb.c22-00684}
}
EUVIMED